[go: up one dir, main page]

MX2018015710A - Análogos fosfolipídicos de éter para la identificación y el aislamiento de células tumorales circulantes. - Google Patents

Análogos fosfolipídicos de éter para la identificación y el aislamiento de células tumorales circulantes.

Info

Publication number
MX2018015710A
MX2018015710A MX2018015710A MX2018015710A MX2018015710A MX 2018015710 A MX2018015710 A MX 2018015710A MX 2018015710 A MX2018015710 A MX 2018015710A MX 2018015710 A MX2018015710 A MX 2018015710A MX 2018015710 A MX2018015710 A MX 2018015710A
Authority
MX
Mexico
Prior art keywords
tumor cells
circulating tumor
isolation
identification
blood
Prior art date
Application number
MX2018015710A
Other languages
English (en)
Inventor
Pinchuk Anatoly
Kozak Kevin
Longino Marc
Pak Chorom
Weichert Jamey
Original Assignee
Cellectar Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectar Biosciences Inc filed Critical Cellectar Biosciences Inc
Publication of MX2018015710A publication Critical patent/MX2018015710A/es

Links

Classifications

    • G01N33/575—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5759—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/12—Measuring magnetic properties of articles or specimens of solids or fluids
    • G01R33/1269—Measuring magnetic properties of articles or specimens of solids or fluids of molecules labeled with magnetic beads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402—Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1488—Methods for deciding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método para identificar, aislar y permitir el análisis corriente abajo de células tumorales circulantes, que comprende poner en contacto a una muestra de sangre o de suero de sangre de un sujeto con una composición que comprende un análogo fosfolipídico de éter ligado a una molécula luminiscente o a una microesfera magnética y someter la muestra de sangre o el suero de sangre del sujeto a microscopia fluorescente, citometría de flujo o aislamiento magnético.
MX2018015710A 2016-06-14 2017-06-14 Análogos fosfolipídicos de éter para la identificación y el aislamiento de células tumorales circulantes. MX2018015710A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662349713P 2016-06-14 2016-06-14
PCT/US2017/037549 WO2017218702A1 (en) 2016-06-14 2017-06-14 Phospholipid ether analogs for the identification and isolation of circulating tumor cells

Publications (1)

Publication Number Publication Date
MX2018015710A true MX2018015710A (es) 2019-06-10

Family

ID=60572525

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015710A MX2018015710A (es) 2016-06-14 2017-06-14 Análogos fosfolipídicos de éter para la identificación y el aislamiento de células tumorales circulantes.

Country Status (16)

Country Link
US (1) US11467159B2 (es)
EP (1) EP3469367B1 (es)
JP (1) JP7136770B2 (es)
KR (1) KR20190037226A (es)
CN (1) CN109791152B (es)
AU (1) AU2017286604B2 (es)
BR (1) BR112018077197A2 (es)
CA (1) CA3027497C (es)
DK (1) DK3469367T3 (es)
EA (1) EA201892663A1 (es)
ES (1) ES2952867T3 (es)
IL (1) IL263687B2 (es)
MX (1) MX2018015710A (es)
NZ (1) NZ749272A (es)
SI (1) SI3469367T1 (es)
WO (1) WO2017218702A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2566847B (en) 2016-05-19 2022-04-20 Univ Leland Stanford Junior Systems and methods for automated single cell cytological classification in flow
EP3338806A1 (en) * 2016-12-21 2018-06-27 Université de Namur Method for functionalising nanoparticles
DK3773544T3 (da) * 2018-04-10 2025-09-15 Cellectar Biosciences Inc Phospholipid-flavaglinkonjugater og fremgangsmåder til anvendelse deraf til målrettet cancerterapi
US11815507B2 (en) 2018-08-15 2023-11-14 Deepcell, Inc. Systems and methods for particle analysis
US10611995B2 (en) 2018-08-15 2020-04-07 Deepcell, Inc. Systems and methods for particle analysis
WO2021050917A1 (en) * 2019-09-12 2021-03-18 Cellectar Biosciences, Inc. Phospholipid ether conjugates as cancer-targeting drug vehicles
WO2021072300A1 (en) 2019-10-10 2021-04-15 Cellectar Biosciences, Inc. Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
KR102400464B1 (ko) * 2020-07-28 2022-05-19 부산대학교 산학협력단 암 줄기세포 검출용 바이오 마커 조성물
US20230251262A1 (en) * 2022-02-09 2023-08-10 Universitaesklinikum Hamburg-Eppendorf Enrichment, detection and characterization of circulating tumor cells with susd2 and enpp1
CN115326683A (zh) * 2022-08-12 2022-11-11 四川成电医联科技咨询有限公司 一种基于阻抗脉冲时延法的磁珠标定的白细胞子分群计数方法
CN115389766B (zh) * 2022-08-29 2023-09-22 深圳市瑞格生物科技有限公司 用于诊断神经母细胞瘤是否发生骨髓浸润的标志物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941689D1 (de) 1998-02-12 2010-01-07 Univ Texas Verfahren und reagenzien zur raschen und effizienten isolierung zirkulierender krebszellen
WO2007013894A2 (en) * 2004-12-20 2007-02-01 Cellectar, Llc Phospholipid ether analogs for detecting and treating cancer
JP2007528374A (ja) * 2004-03-02 2007-10-11 セレクター，リミティド ライアビリティ カンパニー Ｄｉａｐｅｕｔｉｃ（登録商標）剤としてのリン脂質類似体、及びその方法
US8540968B2 (en) 2004-03-02 2013-09-24 Cellectar, Inc. Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
MX2008011839A (es) * 2006-03-13 2008-11-04 Veridex Llc Propagacion de celulas primarias.
US7811548B1 (en) 2009-05-11 2010-10-12 Cellectar, Inc. Fluorescent phospholipid ether compounds and compositions
US20100286510A1 (en) * 2009-05-11 2010-11-11 Pinchuk Anatoly Use of fluorescent phospholipid ether compounds in biopsies
ES2549459T3 (es) * 2009-05-11 2015-10-28 Cellectar, Inc. Compuestos de éter de fosfolípido fluorescentes, composiciones y procedimientos de uso
WO2010151109A1 (en) * 2009-06-26 2010-12-29 Erasmus University Medical Center Rotterdam Identifying circulating tumor cells (ctcs) using cd146 in breast cancers patients
JP2016512197A (ja) * 2013-03-05 2016-04-25 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 間葉及び上皮間葉形質転換循環腫瘍細胞のための特異的検出ツール
JP6052756B2 (ja) * 2014-07-22 2016-12-27 株式会社がん免疫研究所 末梢循環癌細胞の検出方法および検出装置
US9925283B2 (en) * 2015-04-10 2018-03-27 Wisconsin Alumni Research Foundation Alkylphosphocholine analogs for multiple myeloma imaging and therapy

Also Published As

Publication number Publication date
CA3027497A1 (en) 2017-12-21
IL263687B2 (en) 2023-09-01
EP3469367B1 (en) 2023-08-02
WO2017218702A1 (en) 2017-12-21
JP7136770B2 (ja) 2022-09-13
IL263687B1 (en) 2023-05-01
DK3469367T3 (da) 2023-08-28
ES2952867T3 (es) 2023-11-06
US20170356914A1 (en) 2017-12-14
IL263687A (en) 2019-02-03
KR20190037226A (ko) 2019-04-05
CA3027497C (en) 2023-12-05
EA201892663A1 (ru) 2019-05-31
BR112018077197A2 (pt) 2019-08-20
EP3469367A1 (en) 2019-04-17
US11467159B2 (en) 2022-10-11
SI3469367T1 (sl) 2023-10-30
CN109791152B (zh) 2023-03-03
EP3469367A4 (en) 2020-02-19
CN109791152A (zh) 2019-05-21
JP2019528456A (ja) 2019-10-10
AU2017286604B2 (en) 2023-05-18
NZ749272A (en) 2023-01-27
AU2017286604A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
MX2018015710A (es) Análogos fosfolipídicos de éter para la identificación y el aislamiento de células tumorales circulantes.
MX2019010958A (es) Metodos de tratamiento de tumores.
BR112018010933A2 (pt) anticorpos multiespecíficos
BR112017027498A2 (pt) anticorpo, ácido nucleico, composto, composição, e, método para tratamento de um paciente com uma doença.
CO2019002607A2 (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto
BR112014010955A2 (pt) sistema e método para processar amostras
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
MX341517B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
BR112017025297A2 (pt) anticorpos anti-gitr para diagnóstico do câncer
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
MX367366B (es) Composiciones y metodos para diagnosticar tumores de tiroides.
MX2022012824A (es) Metodos para enriquecer vesiculas extracelulares de muestras de liquido biologico.
CO2019002608A2 (es) Biomarcadores de arn para angioedema hereditario
MX2017009485A (es) Detección y aislamiento de células fetales basadas en microfluidos para prueba prenatal no invasiva.
MX2023002326A (es) Firma de localizacion celular e inmunoterapia.
MX2016016742A (es) Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv).
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
PE20180576A1 (es) ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh
AR105379A1 (es) Dispositivo para detectar proteínas mal plegadas y sus métodos de uso
MX365713B (es) Enriquecimiento de células tumorales circulantes por desgaste de glóbulos blancos.
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
MX2022003719A (es) Anticuerpos anti-il-27 y sus usos.
MX2016012278A (es) Deteccion temprana de preeclampsia.
AR087175A1 (es) Analisis de la sialilacion de proteinas
Porqueddu et al. Bioengineered 3D microvessels and complementary animal models reveal mechanisms of Trypanosoma congolense sequestration